National Pharmaceutical Council’s Post

Today in NPC This Week: Part D changes, FDA panel broadens peptide access, generic drug tariffs, and more. 💡 New NPC research finds that Medicare Part D plans are more likely than commercial plans to restrict drug coverage in competitive classes following implementation of the IRA. The study suggests that, on average, 4.5M Medicare beneficiaries lost insurance coverage to previously covered branded medicines across 16 competitive classes. Learn more: https://lnkd.in/egTwGTaf Want to get NPC This Week in your inbox? Subscribe here: https://lnkd.in/ekY9Dxzr